Kidney disease progression and screening cost-effectiveness among African Americans

Journal of the American Society of Nephrology

Volumn 23, Issue 12, 2012, Pages 1915-1916

  Vargas, Roberto B ^a,b,c   Norris, Keith C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; EDITORIAL; ETHNIC DIFFERENCE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LEG AMPUTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA; QUALITY OF LIFE;

EID: 84870542644     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012101028     Document Type: Editorial

References (15)

1. Norris K, Nissenson A: Racial disparities in chronic kidney disease: Tragedy, opportunity, or both? Clin J Am Soc Nephrol 3: 314-316, 2008
2. US Preventive Services Task Force: Screening for chronic kidney disease. Available at: http://www.uspreventiveservicestaskforce.org/uspstf/uspsckd.htm. Accessed October 20, 2012
3. Hoerger TJ, Wittenborn JS, Zhuo X, Pavkov ME, Burrows NR, Eggers P, Jordan R, Saydah S, Williams DE: Kidney disease progression and screening cost-effectiveness among African Americans. J Am Soc Nephrol 23: 2035-2041, 2012
4. Zhuo X: Preserving health among vulnerable populations: Three essays. Available at: http://www.rand.org/content/dam/rand/pubs/rgs-dissertations/2009/ RAND-RGSD245. Accessed October 20, 2012
5. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR: Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA 290: 3101-3114, 2003 (Pubitemid 37548116)
6. Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative: A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis 55: 452-462, 2010
7. Hsu CY, Lin F, Vittinghoff E, Shlipak MG: Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14: 2902-2907, 2003 (Pubitemid 37305653)
8. Derose SF, Rutkowski MP, Levin NW, Liu IL, Shi JM, Jacobsen SJ, Crooks PW: Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease. Kidney Int 76: 629-637, 2009
9. Powe NR: Let's get serious about racial and ethnic disparities. J Am Soc Nephrol 19: 1271-1275, 2008
10. Norris K, Nissenson AR: Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 19: 1261-1270, 2008
11. Rettig R, Vargas R, Norris K, Nissenson ARA: A 'quiet revolution' in nephrology. Nephrol News Issues 24: 18-19, 23, 2010
12. Gao SW, Oliver DK, Das N, Hurst FP, Lentine KL, Agodoa LY, Sawyers ES, Abbott KC: Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system. Clin J Am Soc Nephrol 3: 442-449, 2008
13. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV: Ethnic disparities in diabetic complications in an insured population. JAMA 287: 2519-2527, 2002 (Pubitemid 34517197)
14. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
15. Sox H: The patient-centered outcomes research institute should focus on high-impact problems that can be solved quickly. Health Aff (Millwood) 31: 2176-2182, 2012